106 / 172
Atul Ltd | Annual Report 2015-16
(
`
cr)
Note 13 Non-current investments
1
(continued)
As at
March 31, 2016
As at
March 31, 2015
Long-term investments
Face value
2
Number of
shares
c) Investments in Preference
shares
In subsidiary companies
Atul Bioscience Ltd (6% Cumulative
Redeemable Preference shares)
100
–
(2,00,000)
–
2.00
Atul Bioscience Ltd (10%
Cumulative Redeemable Preference
shares)
100
–
(40,400)
–
0.40
–
2.40
In associate company
Amal Ltd (0% Redeemable Preference
shares) (refer Note 28.14)
10 1,00,00,000
10.00
10.00
B.
Other than trade investments
a) Quoted Equity instruments
In others
Arvind Infrastructure Ltd
3
10 4,12,747
–
–
Arvind Ltd
10 41,27,471
46.64
46.64
BASF India Ltd
10 2,61,396
0.84
0.84
ICICI Bank Ltd
2
99,115
0.14
0.14
Jain Irrigation Systems Ltd
2
4,200
0.02
0.02
Nagarjuna Oil Refinery Ltd
4
1
31,500
–
–
Novartis India Ltd
5 3,84,660
1.02
1.02
Pfizer Ltd
10 9,58,927
1.50
1.50
50.16
50.16
b)
Unquoted equity instruments
In others
Nagarjuna Fertilizers and
Chemicals Ltd
1
34,650
0.04
0.04
c)
Investments in Government or
Trust securities
6 Years National Savings
Certificates (deposited with the
Government departments)
88,000
0.01
0.01
142.60
148.31
C. Share application money
(Subsidiary company)
1.96
0.51
144.56
148.82
Particulars
Book value
as at March 31,
Market value
as at March 31,
2016
2015
2016
2015
Quoted
50.20
50.20 338.81 376.99
Unquoted
92.40
98.11
142.60 148.31
Aggregate provision for diminution
2.54
2.54
1
Valued at cost unless otherwise stated | ² In
`
and fully paid unless otherwise stated
3
Received in terms of demerger scheme |
4
Due to restructuring of company
Notes
to the Financial Statements